Magnetic resonance imaging (MRI) contrast agents (CTs) with both positive () and negative (₂) contrast abilities have attracted considerable interests due to their complementary diagnostic information for more precise diagnosis. In this study, gadolinium-doped oxide nanoparticles functionalized by hyaluronic acid (HA-GdIO NPs) were synthesized for atherosclerosis-targeting -₂ dual-model MR imaging. The results showed that the HA-GdIO NPs exhibited high magnetic susceptibility and good biocompatibility. After being coated with HA, the HA-GdIO NPs specifically accumulated in the atherosclerosis plaques through targeting CD44-overpression macrophages which played a central role in development of atherosclerotic plaques. Furthermore, the HA-GdIO NPs can provide enhanced and ₂ dual phase contrast effects and , particularly in the vascular regions of mice. This work may provide a promising idea to construct MRI contrast agents with both effective and targeted contrast abilities for biomedical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1166/jbn.2019.2660DOI Listing

Publication Analysis

Top Keywords

ha-gdio nps
16
oxide nanoparticles
8
mri contrast
8
contrast agents
8
contrast abilities
8
contrast
5
hyaluronic acid-functionalized
4
acid-functionalized gadolinium
4
gadolinium doped
4
doped iron
4

Similar Publications

Magnetic resonance imaging (MRI) contrast agents (CTs) with both positive () and negative (₂) contrast abilities have attracted considerable interests due to their complementary diagnostic information for more precise diagnosis. In this study, gadolinium-doped oxide nanoparticles functionalized by hyaluronic acid (HA-GdIO NPs) were synthesized for atherosclerosis-targeting -₂ dual-model MR imaging. The results showed that the HA-GdIO NPs exhibited high magnetic susceptibility and good biocompatibility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!